is a glp-1 insulin Science Behind GLP 1 GIP and Glucagon Receptor Agonists for Obesity Research | News & Announcements GLP-1 & GIP Agonists |

received advisory/consulting fees and/or other support from Altimmune, AstraZeneca, Bayer, Biomea, Boehringer Ingelheim, Carmot Therapeutics, Cytoki Pharma, Eli Lilly, Intercept, Janssen/Johnson & Johnson, Mannkind, Mediflix, Merck, Metsera, Novo Nordisk, Pharmaventures, Pfizer, Regeneron, Sanofi, Shionogi, Structure Therapeutics, Target RWE, Terns Pharmaceuticals, The Comm Group, Valeritas, WebMD and Zealand Pharma

In a locomotor activity assay, systemic administration of liraglutide (100 or 200 g/kg, s.c.) dose-dependently reduced cocaine-induced hyperlocomotion (10 mg/kg, i.p.) without altering baseline locomotion

[DOI] [PMC free article] [PubMed] [Google Scholar] 15.Lu M., Ni D., Wu W., Xu C., Zhang Y

10.1210/jendso/bvad114.875 51 LankischP

Endpoints News first reported the agency's reversal

These can include: Redness Swelling Itching Pain These reactions are usually mild and resolve on their own